Company	Share, %
Kodiak Sciences Inc.	32.97
ACADIA Pharmaceuticals Inc.	26.01
Seagen	23.74
Prelude Therapeutics Incorporated	18.43
Sera Prognostics, Inc.	16.76
Incyte	16.11
Replimune Group, Inc.	15.55
Entrada Therapeutics, Inc.	14.48
Neoleukin Therapeutics, Inc.	13
IGM Biosciences, Inc.	11.09
BeiGene, Ltd.	11.06
Kymera Therapeutics, Inc.	9.81
Monte Rosa Therapeutics, Inc.	9.73
Kala Pharmaceuticals, Inc.	9.47
Madrigal Pharmaceuticals, Inc.	9.24
Cerus Corporation	8.89
HOOKIPA Pharma Inc.	8.42
Verastem, Inc.	8.42
Bicycle Therapeutics plc	8.4
Athira Pharma, Inc.	8.23
AbCellera Biologics Inc.	7.82
DBV Technologies S.A.	7.58
Adaptimmune Therapeutics plc	7.09
Kiniksa Pharmaceuticals, Ltd.	7.03
Immatics N.V.	6.77
Atreca, Inc.	6.62
TScan Therapeutics, Inc.	6.39
Aerovate Therapeutics, Inc.	6.03
Biomea Fusion, Inc.	5.87
Immunocore Holdings plc	5.06
BioCryst Pharmaceuticals, Inc.	4.91
2seventy bio, Inc.	4.86
Sagimet Biosciences Inc. Series A Common Stock	4.79
Stoke Therapeutics, Inc.	4.38
Akero Therapeutics, Inc.	4.21
Opthea Limited	4.05
Edgewise Therapeutics, Inc.	3.34
Revolution Medicines, Inc.	3.13
Leap Therapeutics, Inc.	3.06
Achilles Therapeutics plc	2.94
Aligos Therapeutics, Inc.	2.74
Design Therapeutics, Inc.	2.66
Tricida, Inc.	2.37
Taysha Gene Therapies, Inc.	2.14
ARS Pharmaceuticals, Inc.	2.12
TCR2 Therapeutics Inc.	1.92
Denali Therapeutics Inc.	1.87
Celcuity Inc.	1.76
Protara Therapeutics, Inc.	1.75
Perspective Therapeutics, Inc.	1.3
Century Therapeutics, Inc.	0.96